NASDAQ:CLVS

Clovis Oncology - CLVS News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Compare

Today's Range: $0.08
▼
$0.10
50-Day Range: $0.08
▼
$1.09
52-Week Range: $0.08
▼
$3.32

Volume: 1.16 million shs
Average Volume: 8.88 million shs
Market Capitalization: $11.60 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Get Clovis Oncology News Delivered to You Automatically

CLVS Media Mentions By Week

CLVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLVS
News Sentiment
▼
0.00

0.35
▲
Average
Medical
News Sentiment

CLVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLVS Articles
This Week
▼
1

2
▲
CLVS Articles
Average Week

Source

Source	Headline
	Analysts Holding As Pfizer Waits On Two Phase 3 Studies (CLVS) marketbeat.com - February 24 at 9:05 AM
	Luteinizing Hormone Releasing Hormone (LHRH) Agonists Market Growth, Business Development and Analysis Till 2029 marketwatch.com - March 22 at 7:53 PM
	Silicon Valley Bank, a 'strong supporter' of Colorado tech startups, closed by regulators bizjournals.com - March 12 at 10:53 PM
	CLVS.O reuters.com - January 30 at 3:28 PM
	CLVSQ Clovis Oncology, Inc. seekingalpha.com - January 18 at 7:43 PM
	Clovis Oncology forbes.com - January 13 at 1:27 PM
	Firm Retention Summary: Clovis Oncology Inc. wsj.com - January 3 at 12:07 PM
	Cancer drugmaker Clovis files for bankruptcy, hit by falling sales reuters.com - December 12 at 10:38 PM
	Thinking about buying stock in Clovis Oncology, Bank of America, Rivian Automotive, Rent the Runway, or Vipshop Holdings? benzinga.com - December 12 at 5:38 PM
	Boulder drugmaker Clovis Oncology files for bankruptcy bizjournals.com - December 12 at 5:38 PM
	Clovis Plans to Sell Cancer Drug to Novartis in Bankruptcy Deal finance.yahoo.com - December 12 at 5:38 PM
	Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid finance.yahoo.com - December 12 at 5:38 PM
	Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis finance.yahoo.com - December 12 at 5:38 PM
	Cancer Focused Clovis Oncology Files For Bankruptcy benzinga.com - December 12 at 7:58 AM
	Clovis stock slumps amid Chapter 11 filing, to sell FAP-2286 to Novartis for $50M upfront seekingalpha.com - December 12 at 7:26 AM
	Clovis Oncology Shares Fall Premarket After Bankruptcy Filing >CLVS marketwatch.com - December 12 at 7:26 AM
	Clovis Oncology stock slides 10% premarket after company files for bankruptcy finance.yahoo.com - December 12 at 7:26 AM
	Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286 finance.yahoo.com - December 12 at 2:25 AM
	U.S. drugmaker Clovis files for Chapter 11 bankruptcy finance.yahoo.com - December 12 at 2:25 AM
	UPDATE 1-Cancer drugmaker Clovis files for bankruptcy, hit by falling sales finance.yahoo.com - December 12 at 2:25 AM
	Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why finance.yahoo.com - November 25 at 4:04 PM
	Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS) finance.yahoo.com - November 21 at 3:49 PM
	Clovis Oncology Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag finance.yahoo.com - November 11 at 9:06 AM
	Clovis Oncology Shares Nose-Dive As Potential Bankruptcy Filing Looms finance.yahoo.com - November 9 at 5:42 PM
	Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023 finance.yahoo.com - November 9 at 5:42 PM
	Clovis Oncology says could file for bankruptcy in 'very near term' reuters.com - November 9 at 12:41 PM
	Clovis Oncology falls 55% on bankruptcy concerns seekingalpha.com - November 9 at 12:41 PM
	Clovis Oncology Tanks On Possible Bankruptcy Filing nasdaq.com - November 9 at 12:41 PM
	Clovis Oncology: Looking Like An Acquisition Target After Recent Company Updates seekingalpha.com - October 29 at 3:58 AM
	Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat finance.yahoo.com - October 27 at 6:33 PM
	Will Clovis Oncology (CLVS) Report Negative Q3 Earnings? What You Should Know finance.yahoo.com - October 26 at 1:52 PM
	Clovis radiotherapy for tumors shows promise in early-stage study seekingalpha.com - October 17 at 11:55 AM
	Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress finance.yahoo.com - October 17 at 6:42 AM
	Why Is Clovis Oncology (CLVS) Stock Up Today? investorplace.com - October 4 at 1:04 AM
	Clovis Oncology's Rubraca Hits Primary Goal In Prostate Cancer Settings finance.yahoo.com - October 3 at 7:32 PM
	Clovis stock rises 10% as Rubraca shows survival benefit in prostate cancer in confirmatory trial seekingalpha.com - October 3 at 2:31 PM
	TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations finance.yahoo.com - October 3 at 8:45 AM
	Clovis, Isotopia Ink Clinical Supply Pact For Lutetium-177 Used In Its Targeted Cancer Radiation Therapy finance.yahoo.com - September 21 at 4:48 PM
	Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement finance.yahoo.com - September 21 at 11:48 AM
	Clovis files for US, EU approval of Rubraca as initial maintenance therapy for ovarian cancer seekingalpha.com - September 13 at 12:49 PM
	Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer finance.yahoo.com - September 13 at 12:49 PM
	Clovis Oncology's Flagship Ovarian Cancer Drug Improves Progression-Free Survival As First-Line Maintenance finance.yahoo.com - September 12 at 4:47 PM
	Why Is Clovis Oncology (CLVS) Stock Up 11% Today? msn.com - September 12 at 10:52 AM
	Why Is Clovis Oncology Stock Trading Higher Today? msn.com - September 12 at 10:52 AM
	Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups finance.yahoo.com - September 11 at 6:48 PM
	Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound? finance.yahoo.com - September 7 at 6:20 PM
	Clovis Oncology's Return On Capital Employed Overview msn.com - August 30 at 12:25 PM
	The Clovis Oncology, Inc. (NASDAQ:CLVS) Analysts Have Been Trimming Their Sales Forecasts finance.yahoo.com - August 14 at 12:05 PM
	Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q2 2022 Results - Earnings Call Transcript seekingalpha.com - August 8 at 7:21 PM
	Clovis drops 15% amid funding constraints as demand for cancer agent falls seekingalpha.com - August 8 at 7:21 PM
	Why Is Clovis Oncology (CLVS) Stock Down 10% Today? investorplace.com - August 8 at 2:02 PM

Get Clovis Oncology News Delivered to You Automatically

This page (NASDAQ:CLVS) was last updated on 3/23/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Clovis Oncology - CLVS News Today

CLVS Media Mentions By Week

CLVS Media Sentiment

CLVS News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info